Cargando…
Evaluation of cfDNA as an early detection assay for dense tissue breast cancer
A cell-free DNA (cfDNA) assay would be a promising approach to early cancer diagnosis, especially for patients with dense tissues. Consistent cfDNA signatures have been observed for many carcinogens. Recently, investigations of cfDNA as a reliable early detection bioassay have presented a powerful o...
Autores principales: | Barbirou, Mouadh, Miller, Amanda A., Gafni, Erik, Mezlini, Amel, Zidi, Asma, Boley, Nathan, Tonellato, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120463/ https://www.ncbi.nlm.nih.gov/pubmed/35589867 http://dx.doi.org/10.1038/s41598-022-12457-1 |
Ejemplares similares
-
Variant Characterization of a Representative Large Pedigree Suggests “Variant Risk Clusters” Convey Varying Predisposition of Risk to Lynch Syndrome
por: Barbirou, Mouadh, et al.
Publicado: (2023) -
Microfluidic Technologies for cfDNA Isolation and Analysis
por: Xu, Zheyun, et al.
Publicado: (2019) -
In silico error correction improves cfDNA mutation calling
por: Kim, Chang Sik, et al.
Publicado: (2019) -
Impact of cfDNA Reference Materials on Clinical Performance of Liquid Biopsy NGS Assays
por: Hallermayr, Ariane, et al.
Publicado: (2023) -
Combinatorial Power of cfDNA, CTCs and EVs in Oncology
por: Keup, Corinna, et al.
Publicado: (2022)